"Expanded Access" in ClinicalTrials.gov

*NLM Technical Bulletin, Nov-Dec 2009, "Expanded Access" in ClinicalTrials.gov

http://www.nlm.nih.gov/pubs/techbull/nd09/nd09_ct_faq2.html

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.